‘Depression’ at Psychology, Philosophy and Real Life, Page 15

New studies explore the connection between sleep and depression and suggest that treating insomnia may increase both the likelihood and the rate of recovery for individuals receiving treatment for major depression. Additional research examines the first melatoninergic antidepressant, agomelatine (Valdoxan), and its use as an adjunctive therapy for bipolar disorder.

New estimates suggest that bipolar disorder is over 4 times more common than previously believed, and that its cost in terms of lost productivity and higher suicide risk has been significantly underestimated, compared to the more familiar major depressive disorder. New research on lithium shows it is the single most effective psychopharmacological agent for reducing rates of suicide for those affected by bipolar disorder.

The International Conference on Bipolar Disorder, the only venue in the world devoted exclusively to highlighting new research into bipolar disorder, has heard research which brings scientists closer to understanding genetic underpinnings of bipolar disorder.

New research indicates that women who drink to excess are more likely to experience symptoms of anxiety and depression. The report also found the lowest rates of anxiety and depression for women in their 30s were for those who drank lightly.

How adolescents perceive their body weight turns out to be a more important risk factor for suicide than actual body weight.